GHF2012 – PL03 – Innovation & Inclusion for Chronic Diseases: Beyond the Hype

Session Outline

Plenary session PL03, Thursday, April 19 2012, 14:00-15:30, Room 2
Chair(s): Jeffrey M. Blander, Bienmoyo Foundation Director HST939 - Technology Innovation for Global Health Harvard Medical School and MIT, United States
Discussant: Andrew Miller, Bespoke Innovations, San Francisco, United States
Summary: Innovation is the creation of better or more effective products, processes, services, technologies, or ideas that are accepted by markets, governments, and society. Current debates on chronic conditions, tend to mostly revolve around giving people more control on their diseases and life. This session aims to dispel the myth that innovation is necessarily equal to technology. The session will engage the debate around innovation, access, affordability and cultural adaptability.
Innovation is a state of mind…
State-NGO Partnership to Improve the Prevention and Management of Diabetes in Mali
Stéphane Besançon, ONG Santé Diabète, Bamako, Mali
mDiabetes in India: Leveraging Mobile Technology for Chronic Disease Prevention
Nalini Saligram, Arogya World, United States
Why 'Innovation' is the Most Over-Used and Under-Used Term in Healthcare and its Implications for the Continuum of Care
Mahad Ibrahim, Gobee Group, Bellevue, United States

Session Documents

[Download not found]
[Download not found]
[Download not found]
[Download not found]

Session Video

,

One Response to GHF2012 – PL03 – Innovation & Inclusion for Chronic Diseases: Beyond the Hype

  1. David Beran 19/04/2012 at 13:33 #

    Very interesting session! More questions than answers from this session!

    Innovation is not only using new technologies, but also approaches, activities and interventions.

    Innovation also needs to be adapted to the context or even contexts in a given country.

    The example from the Skylight shows an innovative approach throughout the development of a new technology. Innovative funding, use of technology in all phases of design, prototyping and implementation.

    How can these aspects be used to address innovation in global health?

    Innovation is addressing the problem to find a solution. Failure may be the result, but it is part of the learning process. Is there the opportunity to fail in global health? Also is there the space to innovate in global health?

    Two key issues from this session that have been touched upon in other talks are scalability and sustainability. Should these issues be built into the innovative process?

    Conclusion (if possible) – people need to come first and the technology and innovation have to come into play to help with the solution.

Leave a Reply